At Informa: How GLP-1s changed compounding

Going to Informa Connect’s Compounding Pharmacy Compliance Year-End Update in December in Philly? APC CEO Scott Brunner will be there speaking on “How GLP-1s Have Changed Compounding — and What Happens Next” in the general session. 

We all know how GLP-1s have had a huge effect on pharmacy compounding — introducing it to millions of new patients, while also bringing dangerous distortions and misrepresentations. So what does it all mean right now and in the coming months? Scott’ll offer his take immediately following the “Strengthening Trust” keynote, Dec. 9 from 9:50 – 10:25 am. Don’t miss it! And don’t miss APC Chief Advocacy Officer Tenille Davis also presenting at the event: Her “Navigating State Compliance for GLP-1 Compounding” is at 10:55 am.